BENDAMUSTINE MEDAC 100 MG Israel - English - Ministry of Health

bendamustine medac 100 mg

tzamal bio-pharma ltd - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 100 mg - bendamustine - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotherapy is not appropriate.indolent non-hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.

BENDAMUSTINE MEDAC 25 MG Israel - English - Ministry of Health

bendamustine medac 25 mg

tzamal bio-pharma ltd - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 25 mg - bendamustine - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotherapy is not appropriate.indolent non-hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.

BENDAMUSTINE MEDAC 25 MG Israel - English - Ministry of Health

bendamustine medac 25 mg

tzamal bio-pharma ltd - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 25 mg - bendamustine - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotherapy is not appropriate.indolent non-hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.

Bendamustine 25 mg/ml concentrate for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

bendamustine 25 mg/ml concentrate for solution for infusion

accord healthcare ireland ltd. - bendamustine hydrochloride - concentrate for solution for infusion - bendamustine

Bendamustine 25 mg Powder for Concentrate for Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

bendamustine 25 mg powder for concentrate for solution for infusion

actavis group ptc ehf - bendamustine hydrochloride - powder for concentrate for solution for infusion - 25 milligram(s) - nitrogen mustard analogues; bendamustine - antineoplastic agents, alkylating agents - first-line treatment of chronic lymphocytic leukaemia. indolent non-hodgkin's lymphomas. front line treatment of multiple myeloma

Bendamustine 25 mg Powder for Concentrate for Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

bendamustine 25 mg powder for concentrate for solution for infusion

teva b.v. - bendamustine hydrochloride - powder for concentrate for solution for infusion - nitrogen mustard analogues; bendamustine

Levact 25mg Powder for Concentrate for Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

levact 25mg powder for concentrate for solution for infusion

astellas pharma gmbh - bendamustine hydrochloride - pdr/conc/soln for infus - 25 milligram(s) - nitrogen mustard analogues; bendamustine

Levact 100mg Powder for Concentrate for Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

levact 100mg powder for concentrate for solution for infusion

astellas pharma gmbh - bendamustine hydrochloride - pdr/conc/soln for infus - 100 milligram(s) - nitrogen mustard analogues; bendamustine

Bendamustine 100 mg Powder for Concentrate for Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

bendamustine 100 mg powder for concentrate for solution for infusion

actavis group ptc ehf - bendamustine hydrochloride - powder for concentrate for solution for infusion - 100 milligram(s) - nitrogen mustard analogues; bendamustine - antineoplastic agents, alkylating agents - first-line treatment of chronic lymphocytic leukaemia. indolent non-hodgkin's lymphomas. front line treatment of multiple myeloma.